A high incidence of vertebral fracture in women with breast cancer

[1]  T. Powles,et al.  Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer. , 1998, Journal of the National Cancer Institute.

[2]  C. Blomqvist,et al.  Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  T. Powles,et al.  Clodronate decreases the frequency of skeletal metastases in women with breast cancer. , 1996, Bone.

[4]  P. Filipponi,et al.  Cyclical intravenous clodronate in postmenopausal osteoporosis: results of a long-term clinical trial. , 1996, Bone.

[5]  J A Kanis,et al.  Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. , 1994, Bone.

[6]  T. Spector,et al.  Prevalence of vertebral fracture in women and the relationship with bone density and symptoms: The chingford study , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  J. Hayman,et al.  Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. , 1991, Cancer research.

[8]  J. Orloff,et al.  Parathyroid hormone-like proteins: biochemical responses and receptor interactions. , 1989, Endocrine reviews.

[9]  S. Rivkees,et al.  The relationship of gonadal activity and chemotherapy-induced gonadal damage. , 1988, JAMA.

[10]  Hayward Jl,et al.  Assessment of response and recurrence in breast cancer. , 1978 .

[11]  K. Lau,et al.  The diagnosis and management of osteoporosis , 2000, Zeitschrift für Rheumatologie.

[12]  T. Powles,et al.  Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  T. Powles,et al.  Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  L. Melton,et al.  Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study. , 1987, Journal of chronic diseases.

[15]  J. Hayward,et al.  Assessment of response and recurrence in breast cancer. , 1978, Seminars in oncology.